ZVRA: Rapid U.S. growth, global expansion, and a strong pipeline drive rare disease innovation
Focused on redefining rare disease care, the company has rapidly grown its U.S. market for Niemann-Pick type C, expanded globally, and advanced a promising pipeline. Strong financials and robust patient support underpin its strategy, with key regulatory and clinical milestones ahead.Based on Zevra…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.